CN103083601B - Traditional Chinese medical composition for treating pompholyx - Google Patents

Traditional Chinese medical composition for treating pompholyx Download PDF

Info

Publication number
CN103083601B
CN103083601B CN201310065218.0A CN201310065218A CN103083601B CN 103083601 B CN103083601 B CN 103083601B CN 201310065218 A CN201310065218 A CN 201310065218A CN 103083601 B CN103083601 B CN 103083601B
Authority
CN
China
Prior art keywords
parts
radix
pompholyx
chinese medical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310065218.0A
Other languages
Chinese (zh)
Other versions
CN103083601A (en
Inventor
李玉娟
李玉华
徐道明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310065218.0A priority Critical patent/CN103083601B/en
Publication of CN103083601A publication Critical patent/CN103083601A/en
Application granted granted Critical
Publication of CN103083601B publication Critical patent/CN103083601B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medical composition for treating pompholyx. The raditional Chinese medical composition comprises the following active components: 20-40g of radix sophorae flavescentis, 10-30g of Schizonepeta, 20-40g of fructus cnidii, 10-30g of alum, 10-30g of cortex dictamni, 10-30g of radix sileris and 10-30g of radix stemonae. The traditional Chinese medical composition is excellent in effect, simple to prepare, convenient to use and free from toxic and side effects.

Description

A kind of Chinese medicine composition for the treatment of pompholyx
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of pompholyx.
Background technology
Pompholyx claims again dysidria rash, is a kind of of skin eczema, the symmetric side that betides hands or foot.Be occur in the palm sole of the foot vesicle dermatoses modern operating pressure large, spirit is in high-strung state, especially some white collars, have because working environment is limit, brothers' ratio is easier to perspire, the factor such as fungal infection and allergy can cause the generation of pompholyx, and summer is hot, so pompholyx is more common in summer.Because blister, in the flourishing especially place of this sweat gland of trick, be take again as main performance in the position that its occurs, so former, once thinking it and sweat gland sweat relevant, and by its called after pompholyx.Pompholyx symptom is for deeply in property phlysis, and foxtail millet grain, to grain of rice size, slightly exceeds skin surface, and often without blush, symmetry betides the palm sole of the foot and refers to (toe) side.1-2 dries up into bits after week, and can repeatedly occur, companion's scorching hot and pruritus in various degree, and Chang Lianxu shows effect the several years.
At present, the corticosteroids medicines that adopt are treated pompholyx more, but the side effect of hormone medicine is larger, long-time use meeting brings many harmful effects to human body, is therefore necessary to invent a kind of good effect and the little Chinese medicine composition of side effect is treated pompholyx.The present invention makes based on above-mentioned thinking just.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of pompholyx.
In order to realize foregoing invention object, one of technical scheme of the present invention is that raw material composition and the weight proportion thereof of making said composition effective ingredient comprise: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part.
The preferred version of above-mentioned prescription is that raw material composition and the weight proportion thereof of making said composition effective ingredient are: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae.
According to technique scheme, the consumption of each raw material in every secondary Chinese medicine composition is: Radix Sophorae Flavescentis 20-40g, Herba Schizonepetae 10-30g, Fructus Cnidii 20-40g, Alumen 10-30g, Cortex Dictamni 10-30g, Radix Saposhnikoviae 10-30g, Radix Stemonae 10-30 g.
In order to realize foregoing invention object, two of technical scheme of the present invention is that raw material composition and the weight proportion thereof of making said composition effective ingredient are: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part, Radix Scutellariae 10-30 part, Rhizoma Coptidis 10-30 part, Rhizoma Atractylodis 20-30 part, Pericarpium Citri Reticulatae 10-30 part, Poria 10-30 part.
The preferred version of above-mentioned prescription is that the raw material of making said composition effective ingredient forms and weight proportion is 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae, 20 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Rhizoma Atractylodis, 20 parts of Pericarpium Citri Reticulataes, 20 parts, Poria.
According to technique scheme, the consumption of each raw material in every secondary Chinese medicine composition is: Radix Sophorae Flavescentis 20-40g, Herba Schizonepetae 10-30g, Fructus Cnidii 20-40g, Alumen 10-30g, Cortex Dictamni 10-30g, Radix Saposhnikoviae 10-30g, Radix Stemonae 10-30g, Radix Scutellariae 10-30g, Rhizoma Coptidis 10-30g, Rhizoma Atractylodis 20-30g, Pericarpium Citri Reticulatae 10-30g, Poria 10-30g.
It is main that pompholyx shows as deep-seated vesicles, and the traditional Chinese medical science thinks that should belong to damp contains partially, and ailment said due to cold or exposure, damp, pathogenic heat, blood deficiency, worm are excessive etc. is pathogenic main cause.
Radix Sophorae Flavescentis heat clearing and damp drying in the present invention, wind dispelling insecticide; The Herba Schizonepetae loose wind that induces sweat, rash, the skin ulcer that disappears, hemostasis; Fructus Cnidii warming the kidney to invigorate YANG, removing dampness and killing parasites, dispelling wind for relieving itching; The Alumen external parasite killing that can detoxify, dampness removing to stop itchin; Cortex Dictamni heat clearing and damp drying, dispelling wind for relieving itching, removing toxic substances; Radix Saposhnikoviae expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic; The cough-relieving of Radix Stemonae nourishing the lung to keep the adverse QI downward, parasite killing; Radix Scutellariae has heat clearing and damp drying, and removing heat from blood is antiabortive, detoxicating functions; Rhizoma Coptidis heat clearing and damp drying, eliminating fire and detoxication; Rhizoma Atractylodis are drying damp and strengthening spleen, expelling wind and cold, improving eyesight; Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen, in tune, dampness, reduces phlegm; Poria promoting diuresis to eliminate damp pathogen, invigorating the spleen for dissipating phlegm, mind tranquilizing and the heart calming, relieves internal heat anticancer.All medicines share and gather altogether the prescription of dispelling wind damp eliminating, heat-clearing and toxic substances removing, blood enriching and dryness moistening, blood circulation promoting and blood stasis dispelling, and to reach the antipruritic effect of the righting of getting rid of evils, for pompholyx treatment, effect is good.
Usage and dosage of the present invention is: by formula, get each taste Chinese medicine and add the little fire of cold water and endure 15-20 minute, steep hands 15-20 minute while being down to cool or non-scald on hand etc. water temperature.Steep one to three time, an auxiliary medicine every day with 4 days.Used time heats, not boiled, can not add cold water again.During severe symptoms, generally with 2-3 auxiliary medicine, can cure completely.
The invention has the advantages that: effect is good, make simply, easy to use, have no side effect.
Below by clinical experiment, curative effect of the present invention is verified.
1, case selection: choose at random 86 patients, wherein male 44 people, female 42 people, maximum 89 years old, minimum 15 years old, 43 years old mean age, be divided into treatment group (male 22 people, female 21 people) and matched group (male 22 people, female 21 people).
2, Therapeutic Method: treatment cycle is 14 days, treatment group is used the immersion that boils of Chinese medicine composition of the present invention to steep, every day 3 times; Matched group is smeared fluocinonide ointment, every day 3 times.
3, curative effect determinate standard: recovery from illness, herpes all disappears or only stays small pieces skin lesion; Take a turn for the better, the herpes 50-80% that disappears; Invalid, after treatment, skin lesion has no improvement or reviews deterioration.The case load that recovery from illness adds improvement is total effectively case.
4, therapeutic outcome: 23 examples of fully recovering in treatment group, 18 examples that take a turn for the better, invalid 2 examples, total effective rate is 95.3%; 12 examples of fully recovering in matched group, 17 examples that take a turn for the better, invalid 14 examples, total effective rate is 67.4%.
By above-mentioned clinical verification, illustrate that therapeutic effect of the present invention is good, effective percentage is high.
The specific embodiment
Embodiment 1
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 20g, Herba Schizonepetae 10g, Fructus Cnidii 20g, Alumen 10g, Cortex Dictamni 10g, Radix Saposhnikoviae 10g, Radix Stemonae 10g.
Embodiment 2
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 30g, Herba Schizonepetae 20g, Fructus Cnidii 30g, Alumen 20g, Cortex Dictamni 20g, Radix Saposhnikoviae 20g, Radix Stemonae 20g.
Embodiment 3
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 40g, Herba Schizonepetae 30g, Fructus Cnidii 40g, Alumen 30g, Cortex Dictamni 30g, Radix Saposhnikoviae 30g, Radix Stemonae 30g.
Embodiment 4
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 20g, Herba Schizonepetae 10g, Fructus Cnidii 20g, Alumen 10g, Cortex Dictamni 10g, Radix Saposhnikoviae 10g, Radix Stemonae 10g, Radix Scutellariae 10g, Rhizoma Coptidis 10g, Rhizoma Atractylodis 20g, Pericarpium Citri Reticulatae 10g, Poria 10g.
Embodiment 5
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 30g, Herba Schizonepetae 20g, Fructus Cnidii 30g, Alumen 20g, Cortex Dictamni 20g, Radix Saposhnikoviae 20g, Radix Stemonae 20g, Radix Scutellariae 20g, Rhizoma Coptidis 20g, Rhizoma Atractylodis 20g, Pericarpium Citri Reticulatae 20g, Poria 20g.
Embodiment 6
The Chinese medicine composition for the treatment of pompholyx, its raw material forms to be counted by weight: Radix Sophorae Flavescentis 40g, Herba Schizonepetae 40g, Fructus Cnidii 40g, Alumen 30g, Cortex Dictamni 30g, Radix Saposhnikoviae 30g, Radix Stemonae 30g, Radix Scutellariae 30g, Rhizoma Coptidis 30g, Rhizoma Atractylodis 30g, Pericarpium Citri Reticulatae 30g, Poria 30g.

Claims (2)

1. the Chinese medicine composition for the treatment of pompholyx, is characterized in that raw material composition and the weight proportion thereof of making said composition effective ingredient are: Radix Sophorae Flavescentis 20-40 part, Herba Schizonepetae 10-30 part, Fructus Cnidii 20-40 part, Alumen 10-30 part, Cortex Dictamni 10-30 part, Radix Saposhnikoviae 10-30 part, Radix Stemonae 10-30 part, Radix Scutellariae 10-30 part, Rhizoma Coptidis 10-30 part, Rhizoma Atractylodis 20-30 part, Pericarpium Citri Reticulatae 10-30 part, Poria 10-30 part.
2. the Chinese medicine composition for the treatment of pompholyx according to claim 1, is characterized in that raw material composition and the weight proportion thereof of making said composition effective ingredient are: 30 parts of Radix Sophorae Flavescentiss, 20 parts of Herba Schizonepetae, 30 parts of Fructus Cnidiis, 20 parts of Alumens, 20 parts of Cortex Dictamni, 20 parts of Radix Saposhnikoviaes, 20 parts of the Radixs Stemonae, 20 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Rhizoma Atractylodis, 20 parts of Pericarpium Citri Reticulataes, 20 parts, Poria.
CN201310065218.0A 2013-03-01 2013-03-01 Traditional Chinese medical composition for treating pompholyx Expired - Fee Related CN103083601B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310065218.0A CN103083601B (en) 2013-03-01 2013-03-01 Traditional Chinese medical composition for treating pompholyx

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310065218.0A CN103083601B (en) 2013-03-01 2013-03-01 Traditional Chinese medical composition for treating pompholyx

Publications (2)

Publication Number Publication Date
CN103083601A CN103083601A (en) 2013-05-08
CN103083601B true CN103083601B (en) 2014-04-09

Family

ID=48197079

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310065218.0A Expired - Fee Related CN103083601B (en) 2013-03-01 2013-03-01 Traditional Chinese medical composition for treating pompholyx

Country Status (1)

Country Link
CN (1) CN103083601B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105477570A (en) * 2014-09-17 2016-04-13 李丹 Pompholyx treating traditional Chinese medicine composition
CN104888057A (en) * 2015-06-26 2015-09-09 隋缘 Cleansing solution for curing dyshidrosis
CN106421729A (en) * 2016-12-07 2017-02-22 李鹏 Solution for treating dyshidrosis
CN113509512A (en) * 2021-07-30 2021-10-19 谢吉伟 Traditional Chinese medicine for treating herpes zoster and postherpetic pain and preparation method thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292268A (en) * 2000-04-24 2001-04-25 缪振兴 Medicine for curing tinea unguium
CN1413627A (en) * 2002-05-04 2003-04-30 付研彪 Medicine for treating dematosis
CN101120986A (en) * 2006-08-09 2008-02-13 林朝文 Body-clearing itching-relieving liquid
CN101537149A (en) * 2008-03-21 2009-09-23 北京中泰天和科技有限公司 Pharmaceutical composition for curing eczema
CN101537110A (en) * 2009-05-08 2009-09-23 姚洪奎 Soup for detoxifying, removing dampness and relieving itching
CN102475813A (en) * 2010-11-22 2012-05-30 刘宝环 Medicament for treating eczema
CN102614282A (en) * 2012-04-25 2012-08-01 董宜忠 Medicament for treating eczema and preparation method thereof
CN102671084A (en) * 2012-04-21 2012-09-19 廖天源 Medicine of male genital organ cleaning lotion and preparation method thereof
CN102716392A (en) * 2012-06-01 2012-10-10 蒋金洲 External-use traditional Chinese medicine composition for treating sores, abscess and herpes

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1292268A (en) * 2000-04-24 2001-04-25 缪振兴 Medicine for curing tinea unguium
CN1413627A (en) * 2002-05-04 2003-04-30 付研彪 Medicine for treating dematosis
CN101120986A (en) * 2006-08-09 2008-02-13 林朝文 Body-clearing itching-relieving liquid
CN101537149A (en) * 2008-03-21 2009-09-23 北京中泰天和科技有限公司 Pharmaceutical composition for curing eczema
CN101537110A (en) * 2009-05-08 2009-09-23 姚洪奎 Soup for detoxifying, removing dampness and relieving itching
CN102475813A (en) * 2010-11-22 2012-05-30 刘宝环 Medicament for treating eczema
CN102671084A (en) * 2012-04-21 2012-09-19 廖天源 Medicine of male genital organ cleaning lotion and preparation method thereof
CN102614282A (en) * 2012-04-25 2012-08-01 董宜忠 Medicament for treating eczema and preparation method thereof
CN102716392A (en) * 2012-06-01 2012-10-10 蒋金洲 External-use traditional Chinese medicine composition for treating sores, abscess and herpes

Also Published As

Publication number Publication date
CN103083601A (en) 2013-05-08

Similar Documents

Publication Publication Date Title
CN103272199B (en) Frostbite treatment medicine
CN103083601B (en) Traditional Chinese medical composition for treating pompholyx
CN102652805A (en) Medicine for treating rabies
CN1326550C (en) Quick acting analgetic Chinese medicine liquid
CN104027532A (en) Traditional Chinese medicine fomentation paste for treating rheumatism
CN103446502A (en) Traditional Chinese medicine for treating solar dermatitis
CN105853591A (en) Cold-dispelling and moist-removing medicinal liquor
CN105832947A (en) Health-care foot-soaking Chinese herbal medicine powder
CN101647973A (en) Externally applied liquid medicine for treating dermatoneuritis and preparation method thereof
CN103800730A (en) Foot bath powder
CN104288597B (en) A kind of Chinese medicine composition for treating herpes zoster
CN103446325A (en) Traditional Chinese medicine for treating solar dermatitis
CN103182061B (en) Plaster for treating cervical spondylosis and lumbar diseases
CN103446310B (en) Traditional Chinese medicine medicated bath for treating lumbago and leg pain and preparation method thereof
CN104547947B (en) The Chinese medicine composition of cure scapulohumeral periarthritis
CN107375547A (en) A kind of treat triggers the violent Chinese medicine of headache by chill
CN103330792B (en) Traditional Chinese medicine lotion for treating tinea pedes
CN102949507A (en) Traditional Chinese medicine lotion for treating lumbocrural pain and preparation method thereof
CN102579718A (en) Chinese medicament for treating kidney qi deficiency type prostatitis
CN106692838A (en) Traditional Chinese medicine for treating blood heat type acne
CN101249253B (en) Liquid medicine for curing frostbite
CN105079453A (en) Ointment for treating eczema and preparation method thereof
CN106075268A (en) A kind of Chinese medicine composition treating scabies
CN1970044A (en) Medicinal composition for treating rheumatoid arthritis and method for preparing same
CN106729260A (en) A kind of Chinese medicine for treating lung heat type acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140409

Termination date: 20160301

CF01 Termination of patent right due to non-payment of annual fee